Bandingkan Harga & Kinerja Bali Towerindo Sentra Tbk (BALI) vs Kimia Farma Tbk (KAEF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bali Towerindo Sentra Tbk dan Kimia Farma Tbk: Bali Towerindo Sentra Tbk diperdagangkan di Rp1.230 (kapitalisasi pasar 4,94 T, volume 24 jam 1,8 rb), sedangkan Kimia Farma Tbk diperdagangkan di Rp452 (kapitalisasi pasar 2,53 T, volume 24 jam 344,5 rb). Perbedaan utamanya: Bali Towerindo Sentra Tbk lebih besar dari sisi kapitalisasi pasar, dan Kimia Farma Tbk lebih aktif diperdagangkan (344,5 rb vs 1,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BALI | KAEF | |
|---|---|---|
Kapitalisasi Pasar | 4,94 T | 2,53 T |
Volume | 1,8 rb | 344,5 rb |
Lot | 18 | 3,45 rb |
Perputaran | 2,2 jt | 156,07 jt |
Harga Rata-rata | 1.221,11 | 453,03 |
Nilai Transaksi | 2,2 jt | 156,07 jt |
Harga Ekuilibrium Indikatif | 1.250 | 452 |
Volume Ekuilibrium Indikatif | 1 | 4 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bali Towerindo Sentra Tbk
PT Bali Towerindo Sentra Tbk (the Company) was established on July 6, 2006 based on notarial Deed No. 12 of Triska Damayanti, S.H., Notary in Bali. In 2004, the University of Udayana (the largest university in Bali) has conducted a feasibility study on the communications network infrastructure in Badung regency. The study concluded that the current BTS towers are inefficient and unorganized. As a result, it suggests the multi-tenant BTS towers can be optimized by 49 towers for combined GSM and CDMA transmissions compared to more than 100 single tenant towers at present. Based on this study, the local government has imposed regulations known as Peraturan Bupati Badung No. 62/2006 in conjunctions with regulatory and developments of multi-tenant telecommunication towers in Badung. The objective is to prevent the uncontrollable growth of mostly single-tenant operator-owned BTS towers in Badung regency. Adopting the above concept, BALITOWER has made completion to operate 48 BTS towers spread over in Badung’s strategic location, and it has finished constructing 13 BTS towers in Tabanan. The tower leasing business has also given BALITOWER another business opportunity to provide lease service of high capacity microwave transmission to mobile cellular operators. In 2007, BALITOWER has been awarded an operational license for 20 years by the regional government of Badung and Tabanan municipality in Bali province. The license will allow BALITOWER to be the only tower provider to operate in Badung and Tabanan regency which include tourist’ most favorite landscapes and beaches in Bali such as Kuta. Legian, Seminyak, Nusa Dua and Jimbaran. BALITOWER has spotted a dimensions of investing opportunity not only from the attractiveness of Bali island but also is has captured the opportunity in the growth of telecommunication industry perspective.
Selengkapnya di halaman BALI →Tentang Kimia Farma Tbk
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Selengkapnya di halaman KAEF →
